Related references
Note: Only part of the references are listed.Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Jason D. Fontenot et al.
JOURNAL OF IMMUNOLOGY (2017)
Targeting tumour necrosis factor receptor 1 assembly reverses Th17-mediated colitis through boosting a Th2 response
Shin-Huei Fu et al.
GUT (2015)
Methyltransferase G9A regulates T cell differentiation during murine intestinal inflammation
Frann Antignano et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: Rapid symptom resolution and improvements in quality of life
Christopher S. J. Probert et al.
JOURNAL OF CROHNS & COLITIS (2014)
Efficacy of Long-Term 4.0 g/Day Mesalazine (Pentasa) for Maintenance Therapy in Ulcerative Colitis
Kazuhiko Nakao
MEDICAL SCIENCE MONITOR (2014)
Sirolimus ameliorates inflammatory responses by switching the regulatory T/T helper type 17 profile in murine colitis
Hui Yin et al.
IMMUNOLOGY (2013)
Keeping the Bowel Regular: The Emerging Role of Treg as a Therapeutic Target in Inflammatory Bowel Disease
David J. Gibson et al.
INFLAMMATORY BOWEL DISEASES (2013)
New Insights into the Immunological Changes in IL-10-Deficient Mice during the Course of Spontaneous Inflammation in the Gut Mucosa
Ana Cristina Gomes-Santos et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Old formula, new Rx: The journey of PHY906 as cancer adjuvant therapy
Shwu-Huey Liu et al.
JOURNAL OF ETHNOPHARMACOLOGY (2012)
Partial normalization of pubertal timing in female mice with DSS colitis treated with anti-TNF-α antibody
Mark Daniel DeBoer et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Interleukin-33 Ameliorates Experimental Colitis through Promoting Th2/Foxp3+ Regulatory T-Cell Responses in Mice
Lihua Duan et al.
MOLECULAR MEDICINE (2012)
Rectal gel application of Withania somnifera root extract expounds anti-inflammatory and muco-restorative activity in TNBS-induced Inflammatory Bowel Disease
Pankaj Pawar et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2011)
TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation
Trine Olsen et al.
CYTOKINE (2011)
Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases
Warren Strober et al.
GASTROENTEROLOGY (2011)
Genetics and pathogenesis of inflammatory bowel disease
Bernard Khor et al.
NATURE (2011)
Differentiation of Effector CD4 T Cell Populations
Jinfang Zhu et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Inflammatory Bowel Disease
Arthur Kaser et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
All-Trans Retinoic Acid Ameliorates Trinitrobenzene Sulfonic Acid-Induced Colitis by Shifting Th1 to Th2 Profile
Aiping Bai et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
Intestinal Effector T Cells in Health and Disease
Craig L. Maynard et al.
IMMUNITY (2009)
Therapeutic Potential of Helminth Soluble Proteins in TNBS-induced Colitis in Mice
Nathalie E. Ruyssers et al.
INFLAMMATORY BOWEL DISEASES (2009)
Prevention of TNBS-Induced Colitis by Different Lactobacillus and Bifidobacterium Strains Is Associated with an Expansion of γδT and Regulatory T Cells of Intestinal Intraepithelial Lymphocytes
Marianna Roselli et al.
INFLAMMATORY BOWEL DISEASES (2009)
CD4 T-cell differentiation and inflammatory bowel disease
Lauren A. Zenewicz et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice
R. Glauben et al.
GUT (2008)
Th17 cytokines and their emerging roles in inflammation and autoimmunity
Lynette A. Fouser et al.
IMMUNOLOGICAL REVIEWS (2008)
Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increase
Zhongyi Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Treatment of Crohn's disease with leflunomide as second-line immunosuppression
Martin H. Holtmann et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile
Carolin Daniel et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Unravelling the pathogenesis of inflammatory bowel disease
R. J. Xavier et al.
NATURE (2007)
Risks and benefits of biologic therapy for inflammatory bowel diseases
Geert D'Haens
GUT (2007)
The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells
Ivaylo I. Ivanov et al.
CELL (2006)
Critical role of IL-17 receptor signaling in acute TNBS-induced colitis
Z Zhang et al.
INFLAMMATORY BOWEL DISEASES (2006)
Peripheral and intestinal regulatory CD4+CD25high T cells in inflammatory bowel disease
J Maul et al.
GASTROENTEROLOGY (2005)
Management of ulcerative colitis and Crohn's disease
F Baert et al.
ACTA CLINICA BELGICA (2004)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2003)
The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease
MF Neurath et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation
S Read et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
